We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

A new one-pot CRISPR test detects pathogens and genetic variants in 30 minutes with ultra-high sensitivity More...
01 Sep 2026
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Researchers identify RNA markers that improve 90-day mortality prediction in older COVID-19 patients. More...
29 Aug 2026
Image: Researcher Anu Valkna (Photo courtesy of Lilian Mõttus, University of Tartu)

Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency

A single exome-based test detects small and large genetic variants in POI, delivering diagnoses to guide care. More...
28 Aug 2026
Image: QIAsymphony Connect delivers highly concentrated DNA and RNA for sensitive downstream assays, supporting reliable detection in liquid biopsy, oncology, and infectious disease diagnostics (Photo courtesy of Qiagen)

New Automation Platform Standardizes DNA and RNA Extraction Across Clinical Workflows

QIAGEN introduces QIAsymphony Connect IVD platform for automated clinical nucleic acid extraction. More...
28 Aug 2026
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

A tumor-informed ctDNA MRD assay gains expanded coverage to monitor immunotherapy response in late-stage solid tumors. More...
28 Aug 2026
Image Credit: Adobe Stock

Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

A new pair of companion diagnostics expands HER2 testing in metastatic gastroesophageal cancer. More...
27 Aug 2026
Image Credit: Adobe Stock

New Liquid Biopsy Approach Shows Promise for Detecting Breast Cancer Recurrence

A blood-based DNA score distinguishes recurrent from primary breast cancer with strong accuracy. More...
25 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.